![]() |
|||
|
|
|
|
Do JCAHO requirements for pain management apply to patients undergoing autologous donation or therapeutic phlebotomy in a hospital donor center? |
||
|
A member (who is a compliance officer at a hospital blood bank/transfusion service) indicates that her donor services provide ambulatory patient care within a JCAHO accredited institution, and that the institution now needs to comply with a new JCAHO requirement regarding pain management. This requirement is in the JCAHO Comprehensive Accreditation Manual for Ambulatory Care on pain management which talks about pain management in ALL patients, but may apply to hospital donor centers that are 'doing' ambulatory care activity such as drawing autologous blood from patients or therapeutic phlebotomy (or apheresis) for patients. The specific standards that seem to apply are JCAHO Standards PE 1.4, TX 5.4 and PF 3.4: JCAHO Standard PE.1.4 Pain is assessed in all patients. According to the JCAHO, the intent of PE.1.4 is as follows: In the initial assessment, the organization identifies patients with pain. When pain is identified, the patient can be treated within the organization or JCAHO Standard TX.5.4 The patient is monitored during the post procedure period. According to the JCAHO, the intent of TX.5.4 is as follows: The patient is monitored continuously throughout the post procedure period. The following items are monitored:
JCAHO Standard PF.3.4 Patients are educated about pain and managing pain as part of treatment, as appropriate. According to the JCHAO, the intent of PF.3.4 is as follows: When appropriate, patients and families are instructed about understanding pain, the risk for pain, the importance of effective pain management, the pain assessment process, and methods for pain management, when identified as part of treatment. The member wants to know what other institutions are doing (if anything) to comply with the above JCAHO pain management requirements. The member needs guidelines as the scope of a pain management protocol for her institution's blood donor services. She was told that assessment of pain is the fifth vital sign. Does this mean that donor centers must now assess for pain during the donor interview along with other vital signs, and continue to assess until post donation in case the donor complains of possible hematoma? This issue first was announced May 19, but as of June 3 there have been no responses. Surely someone has a comment. |
|||
|
|
Please submit comments to the e-Network Forum. Ira A. Shulman, MD |
||
|
Posted: June 3, 2001
Addenda: |
|
||